GSS — Genetic Signatures Share News
0.000.00%
- AU$19.31m
- -AU$2.48m
- AU$20.32m
Brief: Genetic Signatures Says Quarterly Sales Of A$1.6 Million Down 64%
Brief: Genetic Signatures Says 510(K) Application Submitted To US FDA
Brief: Genetic Signatures Says Influenza B Detection Expected To Impact On Quarter Sales
Brief: Genetic Signatures Posts Qtrly Sales Of A$4.5 Million Mln
Brief: Genetic Announces CFO appointment
Brief: Genetic Signatures Says Qtrly Sales Down 58% Q/Q
Brief: Genetic Signatures Ltd Says Peter Manley Has Resigned From His Role As Chief Financial Officer
Brief: Genetic Signatures Says HY Revenues From Ordinary Activities Down 52% To A$10.4 Million
Brief: Genetic Signatures Says Quarterly Sales Down 12% From Preceding Quarter
Brief: Genetic Signatures Records Quarterly Sales Of A$5.7 Mln
Brief: Genetic Signatures Posts A$35.4 Mln FY Sales
Brief: Genetic Signatures Says Quarterly Sales Of A$8.7 Million, Up 108% On Q3 Fy2021
Brief: Genetic Signatures Says Public Health Wales Awards Enteric Testing Contract To Genetic Signatures
Australia's Genetic Signatures sees best day in about two weeks on contract with Wales firm
Australia Stock Exchange release from GENETIC SIGNATUR : S&P DJI Announces March 2022 Quarterly Rebalance
Australia Stock Exchange release from GENETIC SIGNATUR : PRE_NR Ends: 17:13:11
Australia Stock Exchange release from GENETIC SIGNATUR : Company presentation
Australia Stock Exchange release from GENETIC SIGNATUR : PRE_NR Ends: 09:08:29
Australia Stock Exchange release from GENETIC SIGNATUR : Half Yearly Report and Accounts